Prescription drug · ANDA
Rivastigmine Tartrate NDC 62135-903
Rivastigmine tartrate 6 mg/1 · Capsule · Oral · Chartwell RX, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-903-60 | 6213509036062135090360 | 60 CAPSULE in 1 BOTTLE (62135-903-60)Marketed from Jan 4, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rivastigmine Tartrate
- Generic name (nonproprietary)
- rivastigmine tartrate
- Active ingredients
- Rivastigmine tartrate — 6 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Chartwell RX, LLCNDC labeler code 62135
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207797
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 62135-903_070bd281-9772-c587-e063-6294a90a04a2SPL ID 070bd281-9772-c587-e063-6294a90a04a2SPL set ID 2bb5e0d6-f677-4021-9888-3ff90979ef7dRxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0362135901608, 0362135903602, 0362135902605, 0362135900601
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135090360followed by a unit qualifier and the quantityPackage 62135-0903-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Rivastigmine tartrate is an acetylcholinesterase inhibitor indicated for treatment of: Mild to moderate dementia of the Alzheimer’s type ( 1.1 ) Mild to moderate dementia associated with Parkinson’s disease ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia associated with Parkinson’s disease.
Excerpt only. Read the full label for complete information.
About NDC 62135-903
- What is NDC 62135-903?
- 62135-903 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 6 mg/1 capsule, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Rivastigmine Tartrate.
- What is the active ingredient?
- Rivastigmine tartrate.
- Who is the labeler?
- Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Rivastigmine Tartrate?
- 36 other product NDCs are listed under this name. See all Rivastigmine Tartrate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Rivastigmine Tartrate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | American Health Packaging | 60687-777 | 60687-0777-01 |
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-063 | 62332-0063-1062332-0063-3062332-0063-60+2 more |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-064 | 62332-0064-1062332-0064-3062332-0064-60+2 more |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-065 | 62332-0065-1062332-0065-3062332-0065-60+2 more |
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-066 | 62332-0066-1062332-0066-3062332-0066-60+2 more |
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-011 | 72241-0011-0372241-0011-10 |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-012 | 72241-0012-0372241-0012-10 |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-013 | 72241-0013-0372241-0013-10 |
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-014 | 72241-0014-0372241-0014-10 |
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-900 | 62135-0900-60 |
Other NDCs under ANDA 207797
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-900 |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-901 |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-902 |